Chanakya

Login

Credent Connect N Care IPO

Published: 10 August 2026 | 6.00 AM
Last Updated: 10 August 2026 | 10.00 AM

IPO Snapshot

Particulars Details
Chanakya View 🔴 Avoid at Current Valuation
Overall Rating ⭐⭐½☆☆ (2.5/5)
GMP Today Not Available
Issue Size Rs. 93.90 Crore
Fresh Issue 49,68,000 shares
Offer for Sale Nil
Issue Price Rs. 189 per share
Lot Size 600 Shares
Minimum Retail Application 1,200 shares—Rs. 2,26,800
IPO Opens 13 August 2026
IPO Closes 17 August 2026
Allotment 18 August 2026
Listing 20 August 2026
Exchange NSE SME
Lead Manager Hem Securities Ltd.
Registrar KFin Technologies Ltd.

Investor Decision Box

Question Chanakya View
Suitable for Listing Gain? 🔴 Only if GMP and QIB demand become strong
Suitable for Long-Term? 🔴 Valuation appears expensive
Risk Level High
Business Quality ⭐⭐⭐⭐☆
Financial Strength ⭐⭐⭐☆☆
Balance Sheet ⭐⭐⭐☆☆
Growth Potential ⭐⭐⭐⭐☆
Valuation Comfort ⭐☆☆☆☆

👉 | IPO GMP | IPO Reviews | IPO Subscription | IPO Allotment

Chanakya View

Credent Connect N Care offers exposure to specialised healthcare logistics, cold-chain solutions, warehousing and technology-enabled courier aggregation. Its transportation of diagnostic samples and reagents gives the company a differentiated position within the logistics industry.

The IPO consists entirely of fresh shares, which is positive because no money will go to selling shareholders. The proceeds are proposed to support working capital, healthcare machinery, debt repayment and general corporate purposes.

However, valuation is the biggest concern. At Rs. 189 per share, the IPO is valued at a post-issue market capitalisation of approximately Rs. 344.40 crore. Based on FY25 PAT of Rs. 2.25 crore, the implied post-issue P/E is approximately 153 times, which appears highly expensive.

Chanakya Recommendation: 🔴 Avoid at Current Valuation

Listing-gain investors should reconsider only if GMP becomes strong and the issue receives convincing QIB and overall subscription demand.

About the Company

Incorporated in 2015 and headquartered in New Delhi, Credent Connect N Care operates across logistics, cold-chain services, warehousing, supply-chain management, courier operations and healthcare support.

The company transports diagnostic samples from collection centres to laboratories and between healthcare facilities. It also provides reagent-movement services to in-vitro diagnostic companies.

Its C3 Post courier-aggregation platform provides pan-India pin-code coverage for bulk shipping. The company positions itself as an integrated B2B service provider combining logistics, technology and specialised healthcare distribution.

Why This IPO Stands Out

✅ Specialised presence in diagnostic-sample and healthcare logistics.

✅ Integrated services covering cold chain, warehousing and transportation.

✅ C3 Post offers pan-India courier aggregation and bulk shipping.

✅ Entire IPO is a fresh issue with no OFS component.

✅ Proceeds will support working capital, machinery and debt repayment.

✅ September 2025 KPIs indicate improved margins and return ratios.

Key Risks

⚠ The implied FY25 post-issue P/E of around 153 times is extremely demanding.

⚠ PAT declined from Rs. 2.70 crore in FY23 to Rs. 2.25 crore in FY25.

⚠ FY25 total income increased only around 3% despite improvement in EBITDA.

⚠ The minimum retail application of Rs. 2,26,800 creates substantial SME exposure.

⚠ Healthcare logistics requires strict temperature control and timely delivery.

⚠ NSE SME shares can experience low liquidity and sharp price volatility.

Financial Snapshot (Rs. Crore)

Particulars FY25 FY24 FY23
Total Income 78.23 76.02 59.93
EBITDA 4.99 4.30 0.41
PAT 2.25 2.66 2.70
Net Worth 15.90 13.66 10.99
Assets 29.50 26.41 19.49

Chanakya Interpretation: EBITDA improved, but declining PAT remains a concern. The valuation assumes substantial future earnings growth, leaving little margin for disappointment.

Business Quality Score

Parameter Rating
Business Model ⭐⭐⭐⭐☆
Industry Outlook ⭐⭐⭐⭐☆
Financial Performance ⭐⭐⭐☆☆
Healthcare Opportunity ⭐⭐⭐⭐☆
Balance Sheet ⭐⭐⭐☆☆
Valuation ⭐☆☆☆☆

IPO Proceeds and Why They Matter

PurposeAmount
Investment in subsidiary for working capitalRs. 17.89 crore
Subsidiary’s machinery expenditureRs. 2.05 crore
Company’s working-capital requirementsRs. 26.30 crore
Repayment of borrowingsRs. 4.12 crore
General corporate purposesBalance amount

The IPO is entirely a fresh issue, allowing Credent Connect N Care to deploy capital towards business expansion. Working capital is the principal requirement because healthcare logistics involves vehicles, storage infrastructure, temperature-controlled movement and customer credit cycles.

Investors should verify the final prospectus because the stated objects amount to Rs. 50.36 crore, whereas 49,68,000 shares at Rs. 189 indicate a gross issue size of approximately Rs. 93.90 crore.

Business Outlook

India’s healthcare-logistics industry could benefit from expanding diagnostic services, organised laboratory networks, growing pharmaceutical distribution and demand for temperature-controlled transportation.

Credent’s specialised healthcare-logistics platform and C3 Post courier aggregation business provide growth opportunities. However, sustained expansion will depend on client acquisition, shipment volumes, asset utilisation and operational execution.

Strengths vs Concerns

StrengthsConcerns
Specialised healthcare logisticsExpensive FY25 valuation
Pan-India courier coverageDeclining PAT
Entirely fresh issueWorking-capital-intensive model
Diversified logistics servicesSME liquidity risk
Improved latest KPIsExecution and cold-chain risks

IPO Valuation

At Rs. 189 per share, the post-issue market capitalisation is approximately Rs. 344.40 crore. Based on FY25 PAT of Rs. 2.25 crore, the implied post-issue P/E is around 153 times.

This valuation appears demanding for a company whose PAT declined from Rs. 2.70 crore in FY23 to Rs. 2.25 crore in FY25. Even though September 2025 margins and return ratios improved, updated earnings must demonstrate that this improvement is sustainable.

Who Should Apply?

Investor TypeSuitability
Listing-gain investorsOnly with strong GMP and QIB demand
Long-term investorsWait for earnings improvement
Conservative investorsAvoid
High-risk SME investorsConsider only after subscription confirmation

Final Investment Decision

Credent Connect has an attractive healthcare-logistics business and will receive the entire IPO proceeds. However, its expensive valuation, declining historical profit and SME liquidity risk outweigh these positives.

Chanakya View: 🔴 Avoid at the current valuation.

Investors seeking listing gains should reconsider only if GMP becomes convincing, QIB subscription strengthens and overall demand remains robust.

Five FAQs

1. What is Credent Connect IPO’s price?
Rs. 189 per share.

2. What is the minimum retail investment?
Rs. 2,26,800 for 1,200 shares.

3. Is the IPO entirely fresh?
Yes, there is no OFS.

4. Is the valuation attractive?
No, the FY25 implied P/E appears expensive.

5. What is the final recommendation?
Avoid unless GMP and institutional demand become exceptionally strong.

Leave a Reply

Your email address will not be published. Required fields are marked *